German science and technology company Merck is once again cutting jobs in the face of weakening business. Merck, which is based in the western German city of Darmstadt, will cut up to 230 jobs in its ...

DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany (DAX: MRK), a leading science and technology company, and SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a Stamford, ...

(Reuters) - Germany's Merck KGaA said on Thursday it is in late-stage talks to acquire U.S.-based SpringWorks Therapeutics for about $3.5 billion, a deal that could give it access to a recently ...

Germany’s Merck MRK-1.31%decrease; red down pointing triangle KGaA said it is in advanced talks for a potential acquisition of SpringWorks Therapeutics, a U.S. biopharmaceutical company that ...

FRANKFURT, June 11 (Reuters) - Merck KGaA will invest $29.8 million in U.S. biotech company Archemix Corp. as the companies expand an alliance to develop aptamer-based therapeutics for treating cancer ...

German science and technology major Merck KgaA reported on Thursday that its fiscal 2023 profit after tax fell 15.1% to €2.83 billion ($3.08 billion) from last year's €3.34 billion. Earnings per share ...

Merck Group, the German pharmaceutical company, saw its Frankfurt-listed shares fall 10% on Tuesday morning after the company said it had decided to call off a Phase III trial of its cancer drug ...

Effective branding is important for any company. But it becomes even more important when you share a name with another company--especially when that other company is your rival. That's long been the ...

LONDON/FRANKFURT, Sept 11 (Reuters) - A new analysis of data from a clinical trial of Merck KGaA's oral drug cladribine has underscored its potential as a treatment for multiple sclerosis, researchers ...

– Purchase price of $47 per share in cash represents an equity value of approximately $3.9 billion, or an enterprise value of $3.4 billion (€3.0 billion) – – Planned acquisition will immediately add ...